immunotherapy

MaaT Pharma set to showcase groundbreaking preclinical results in cancer immunotherapy

Preclinical findings will be presented at the American Association for Cancer Research (AACR) Annual Meeting in Chicago.

Resetting the immune system: HMOs as a promising treatment for Gut-Brain Axis disorders

Emil Chuang, Chief Medical Officer at Intrinsic Medicine, explores the growing understanding of gut-brain axis disorders and the potential of Human Milk Oligosaccharides (HMOs) in their treatment. 

Bacteria and other microbial signatures may predict immunotherapy success

The presence of specific microbes in the gut microbiota can serve as biomarkers for predicting the efficacy of immunotherapy.

Gut bacteria may improve response to immunotherapy in people with melanoma

Specific gut microbiota features correlate with better responses to immunotherapy in people with melanoma.

Microbio’s MS-20 shows breakthrough potential in enhancing Keytruda for advanced lung cancer

The study revealed that MS-20 dramatically improved treatment outcomes, tripling the objective response rate (ORR) to 75% when combined with Keytruda.

Gut dysbiosis and cancer: new insights into immunotherapy resistance and patient survival

Microbiomepost discussed with Lisa Derosa, oncologist at Gustave Roussy Hospital in Paris, about the link between gut dysbiosis and cancer, shedding light on its role in immunotherapy resistance and patient…

Ratio of gut microbial communities can predict response to cancer therapy

The balance of specific microbes in the gut can help predict who will respond to immunotherapy drugs.

A specific strain of gut bacteria boosts cancer therapy in mice

The findings of a recent study suggest that the combination of anti-PD-1 immunotherapy with a lack of TREM2 generates a gut environment that promotes inflammation, which improves tumor rejection.

Vitamin D boosts cancer immunity by altering gut bacteria

The findings uncover a link between vitamin D, the immune system and gut bacteria, and they suggest that vitamin D levels could be important for cancer immunity and the efficacy…

How some gut microbes improve responses to cancer immunotherapy

The findings of a recent study suggest that L. johnsonii or its metabolite IPA could be used as a microbial-based approach to improve a person’s response to immunotherapy.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top